Alex Kentsisمشاهده پروفایل
استادیار
Alex Kentsis is an Assistant Professor of Pediatrics at the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College of Cornell University. He leads the Kentsis Research Group within the Molecular Pharmacology Program at the Sloan Kettering Institute and the Tow Center for Developmental Oncology. His research focuses on understanding the fundamental causes of childhood and developmental cancers to develop definitive therapies. Dr. Kentsis's research spans several key areas in cancer biology: Functional proteomics and genomic plasticity of refractory childhood cancers Genomic plasticity and somatic DNA transposases and nucleases in developmental cancers Epigenetic signaling and its therapeutic blockade in leukemias and solid tumors High-accuracy mass spectrometry for the discovery and drugging of cancer proteomes His recent publications reveal a strong focus on understanding why young people develop cancer, with particular emphasis on transposase-derived mechanisms like PGBD5 in childhood cancer mutagenesis. His work bridges proteomics, genomics, and epigenetics to develop novel therapeutic approaches for pediatric cancers, especially targeting DNA damage response pathways and epigenetic regulators. Dr. Kentsis has developed computational biology tools such as ProteomeGenerator2 and BarcodeBabel that enable precise, genome-scale proteogenomic analysis. Dr. Kentsis leads a multidisciplinary research group comprising physicians and scientists studying cancers affecting children and young adults, from embryonal tumors in infants to leukemias and brain tumors in children, and sarcomas in young adults. His lab develops innovative approaches for therapeutic drug delivery and proteomic screening to advance cancer treatment.



